Befejeződött1. fázis
A Study to Evaluate the Effect of TRIV-509 on Skin Barrier Function in Patients with Atopic Dermatitis.
Key facts
- Where
- Leiden, HollandiaSee the site
- Phase
- 1. fázis
Where in Hollandia
- Centre for Human Drug ResearchLeiden, HollandiaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Triveni Bio Inc.
- Trial code
- EU 2025-522635-34-00
- Record updated
- 2026. január 21.